Junko Tanaka
Overview
Explore the profile of Junko Tanaka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
348
Citations
4165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tanaka J, Nakagawa T, Ono Y, Kamura Y, Ishida T, Kawabata H, et al.
Mol Oncol
. 2025 Mar;
PMID: 40077847
Pancreatic intraepithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasms (IPMNs) are pancreatic ductal adenocarcinoma (PDAC) precursor lesions. Detecting these precursors and monitoring their progression are crucial for early PDAC diagnosis....
2.
Nishimura T, Tada T, Akita T, Kondo R, Suzuki Y, Imajo K, et al.
J Gastroenterol
. 2025 Feb;
PMID: 39992415
Background: Attenuation Imaging (ATI) and controlled attenuation parameter (CAP) are non-invasive ultrasound-based methods for diagnosing hepatic steatosis. However, reports on the clinical usefulness of ATI are limited. We aimed to...
3.
Ota Y, Yumiya Y, Chimed-Ochir O, Hasegawa A, Yoshida T, Nagata T, et al.
BMJ Open
. 2025 Feb;
15(2):e088377.
PMID: 39987009
Objective: The purpose of the study is to compare the prevalence and associated risk factors of smell and/or taste disorders depending on different virus strains in Hiroshima, Japan. Design: A...
4.
Nagata T, Chimed-Ochir O, Yumiya Y, Tanaka J, Kuwabara M, Kitahara K, et al.
BMC Public Health
. 2025 Feb;
25(1):681.
PMID: 39972366
Background: By May 7, 2023, COVID-19 had significantly impacted Japan, with 33,728,909 infections and 74,663 deaths reported. Hiroshima Prefecture alone recorded 816,354 cases and 1,373 deaths. The World Health Organization...
5.
Razavi H, Waked I, Qureshi H, Kondili L, Duberg A, Aleman S, et al.
J Hepatol
. 2025 Feb;
PMID: 39914746
Background And Aims: The year 2023 marked the 10-year anniversary of the launch of direct-acting antivirals (DAAs) for the treatment of the hepatitis C virus (HCV). HCV treatment trends by...
6.
Kaneyasu Y, Fujiwara H, Akita T, Tanaka J, Shibata Y, Nakagawa T, et al.
Jpn J Radiol
. 2025 Jan;
PMID: 39849242
Purpose: This study aimed to investigate whether vitamin K (menatetrenone) suppresses bone mineral density (BMD) loss in the irradiated region after radiotherapy (RT) in uterine cancer patients. Materials And Methods:...
7.
Ohira M, Imaoka Y, Sato K, Imaoka K, Bekki T, Yano T, et al.
PLoS One
. 2025 Jan;
20(1):e0313102.
PMID: 39820189
Bloodstream infections (BSIs) are significant postoperative complications associated with high mortality rates after liver transplantation (LT). Natural killer (NK) cells, which are key components of the innate immune system, have...
8.
Kimura M, Nishikawa T, Shimakami T, Terashima T, Horii R, Fukuda M, et al.
Glob Health Med
. 2025 Jan;
6(6):404-415.
PMID: 39741996
Hepatitis B and C (HBV and HCV) testing has been performed in Japan since 2002 and is subsidized by central and prefectural governments. A follow-up program for HBV- or HCV-infected...
9.
Gotoh T, Kumada T, Ogawa S, Niwa F, Toyoda H, Hirooka M, et al.
Liver Int
. 2024 Dec;
45(1):e16210.
PMID: 39673700
Background And Aims: This study prospectively compared the diagnostic accuracies of the improved Attenuation Measurement (iATT) algorithm and the Controlled Attenuation Parameter (CAP) and assessed the interchangeability of iATT with...
10.
Sugiyama A, Kataoka M, Tokumo K, Abe K, Imada H, Sun B, et al.
J Epidemiol
. 2024 Dec;
PMID: 39647911
BackgroundWith global aging, especially in Asia, preventing pneumonia among seniors is vital. The necessity of introducing pneumococcal vaccines among the elderly has been highlighted but there is a paucity of...